Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.
about
Fertility preservation during cancer treatment: clinical guidelinesWhat threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.Preserving fertility in patients undergoing treatment for breast cancer: current perspectives.Prospective study of fertility concerns and preservation strategies in young women with breast cancerFertility preservation in women with cancer.Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.Folliculogenesis Is Not Fully Inhibited during GnRH Analogues Treatment in Mice Challenging Their Efficiency to Preserve the Ovarian Reserve during Chemotherapy in This Model.Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study.Understanding Fertility in Young Female Cancer Patients.Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in SurvivorsFemale fertility preservation: a clinical perspective.Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.GnRH and GnRH receptors in the pathophysiology of the human female reproductive system.Late endocrine effects of childhood cancer.News on the medical treatment of young women with early-stage HER2-negative breast cancer.Fertility in Women of Reproductive Age After Breast Cancer Treatment: Practice Patterns and Outcomes.Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?Barriers and facilitators towards fertility preservation care for cancer patients: a meta-synthesis.GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.Recovery of ovary function impaired by chemotherapy using Chinese herbal medicine in a rat model.
P2860
Q26823947-4A66E8EA-B680-44D7-8952-8915C3275C25Q28275450-F89576CF-C54D-4D13-B485-727C9F62DB5EQ30360464-BA4F54B0-344E-4007-8508-EF5721448F28Q33939688-576C1BDE-C697-458A-BB22-3F4A19C43FD2Q34184805-F1A7E1C5-25E2-45A8-84BD-57EF16E3068AQ34729392-8E74DEF7-0801-44C0-B84C-52F6896B36DFQ35511100-689FE26A-3950-4B06-9CD2-87EF340D5C56Q35760872-CC81F737-EABC-4F64-AACD-598920BFF223Q35766397-EEE5141B-E4E6-4536-B343-707C0326FDFEQ36032817-71AE4F22-19B4-4D12-8268-FF2638124D58Q36218039-E5710E2B-D288-41C7-828D-B7BD3EBA1FDAQ36478738-30D8CDFA-9BF6-40AC-A9DD-B614FBC88B6FQ37628888-087F0800-FD76-4118-A988-CFAD16ABF42BQ38397291-6472BF88-E4A0-4702-9170-7004E79DAF46Q38682630-77694BDF-E52B-474A-B68F-4F188967CF97Q38794942-FA45875D-BEBD-4E6F-ACF5-52663454D24EQ38870541-76FABE2A-1698-4B9F-A064-287B34CB1899Q38873690-8291C8FC-3DE1-4113-A5AA-72A9FB191F16Q38968531-E0B5C0E9-F2B8-4DC7-B1AA-4E249CB041D2Q39026680-EC86151E-B3B3-4D07-9F23-DF351EFC3A8DQ40202369-CAADA65B-39EF-40B6-8EB8-913D6B44C993Q40432160-74FA2689-2771-417E-8F00-384967C7F8C1Q40828932-A1AB7358-FA37-4807-A8BC-13B667DFD716Q47643562-07C1FE44-6419-4F59-B9E6-E0409E94AF22
P2860
Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Utility of gonadotropin-releas ...... the benefit remains uncertain.
@en
type
label
Utility of gonadotropin-releas ...... the benefit remains uncertain.
@en
prefLabel
Utility of gonadotropin-releas ...... the benefit remains uncertain.
@en
P2093
P2860
P356
P1433
P1476
Utility of gonadotropin-releas ...... the benefit remains uncertain.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDT196
P577
2013-05-24T00:00:00Z